# Bonum Therapeutics, Inc. — Form D

Bonum Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-17. The offering totals $32.3M, of which $26.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-04-17
- Form: D
- Accession: 0001898714-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $32.3M
- Amount sold: $26.9M
- Remaining: $5.4M
- Investors: 8
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-580902

## Issuer

- Name: Bonum Therapeutics, Inc.
- CIK: 0001898714
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1150 EASTLAKE AVENUE E SUITE 1100, SEATTLE, WA, 98109
- Phone: 206-888-8485

## Officers, directors & promoters (22)

| Name | Role | Location |
| --- | --- | --- |
| Gaurav Aggarwal | Related Person | Palo Alto, CA |
| Samuel Bjork | Related Person | Cambridge, MA |
| Samuel Blackman | Related Person | Seattle, WA |
| Karl Handelsman | Related Person | Grand Prairie, TX |
| Diane Hollenbaugh | Related Person | Seattle, WA |
| John McKearn | Related Person | Seattle, WA |
| John Mulligan | Related Person | Seattle, WA |
| Mitchell Mutz | Related Person | Seattle, WA |
| Neela Patel | Related Person | Seattle, WA |
| Monique Schiersing | Related Person | Seattle, WA |
| Nicholas Walrod | Related Person | Minneapolis, MN |
| Karl Handelsman | Director | Grand Prairie, TX |
| Nicholas Walrod | Director | Minneapolis, MN |
| Samuel Bjork | Director | Cambridge, MA |
| Mitchell Mutz | Director | Seattle, WA |
| Diane Hollenbaugh | Executive Officer | Seattle, WA |
| John Mulligan | Director | Seattle, WA |
| John Mulligan | Executive Officer | Seattle, WA |
| John Mulligan | Promoter | Seattle, WA |
| Monique Schiersing | Director | Seattle, WA |
| John McKearn | Director | Seattle, WA |
| Neela Patel | Executive Officer | Seattle, WA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-11-29](https://search.stillhousedata.com/formd/0001898714-22-000001) | D | $93.0M | $45.0M |
| [2021-12-22](https://search.stillhousedata.com/formd/0001898714-21-000001) | D | $3.6M | $1.2M |

## More

- [CIK 1898714 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1898714&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001898714-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.